Are ‘Poop Pills’ the Future of Peanut Allergy Treatment?

• A preliminary examine discovered that “poop drugs” — oral fecal microbiome transplantation (FMT) — elevated tolerance to peanuts in some adults with a peanut allergy.
• Researchers discovered comparable leads to mice, with a sure kind of intestine micro organism enjoying a key position.
• Whereas the findings are promising for future trials, it’s too quickly to suggest FMT as a remedy for peanut allergy.

A small medical trial means that fecal microbiome transplantation (FMT), or “poop drugs,” might enhance peanut tolerance in adults with peanut allergy symptoms.

The analysis, revealed on August 5 in Science Translational Medicine, investigated whether or not receiving a fecal transplant from a wholesome donor might scale back the severity of peanut allergy.

Some members discovered that their tolerance to peanuts elevated. In an animal mannequin, researchers discovered that mice receiving FMT from the human members had been additionally protected towards the allergy.

“This landmark examine was the primary to reveal {that a} microbiome-based remedy might enhance food allergy in folks whereas additionally revealing how gut bacteria, their metabolites, and the immune system work collectively to affect remedy response,” stated examine creator Rima Rachid, MD, in a news release.

Among the many examine’s 15 members, 6 skilled elevated tolerance to peanuts.

There have been two phases to the human trial. Within the first stage, 10 people acquired frozen FMT from donors with wholesome gut microbiomes. They took 36 drugs in both 1 or 2 days. 4 months later, 3 in 10 folks skilled an elevated tolerance to peanuts.

The second stage concerned 5 members who had taken antibiotics earlier than receiving FMT. The examine discovered that 3 in 5 people had an elevated peanut tolerance.

Amongst those that skilled elevated tolerance, FMT elevated the variety of immune cells referred to as RORγt+ regulatory T cells, which assist regulate the immune system.

“The primary purpose of the examine was to judge for security within the meals allergic inhabitants, and not one of the sufferers had severe hostile occasions,” Rachid advised Healthline.

“One of many secondary goals of the examine was to judge if FMT might enhance the edge dose that sufferers react to, given the promising information we present in mice. It was very encouraging to see that some sufferers tolerate extra peanut protein following a single dose of FMT,” Rachid stated.

Mohammad Bakhtiar, MD, PhD, a basic practitioner and medical lead at Medical Specific Clinic, wasn’t concerned within the examine however shared his ideas on the findings.

“The intestine microbiome already has a significant impact on many elements of human physiology so meals allergy sitting in that checklist is sensible,” Bakhtiar advised Healthline.

“What this examine can not do is inform us how nicely it really works in the actual world; 15 folks is a begin, nevertheless it’s not one thing that may essentially apply throughout populations. Six improved, however 9 didn’t. It’s nonetheless a tiny, open-label part 1 examine. I might deal with it as an early sign, not a change in apply,” he stated.

Following the trial, researchers sampled the microbiomes of members with elevated peanut tolerance and transplanted them into mice. The mice had been then protected towards the allergy because of the elevated RORγt+ regulatory T cells.

The authors famous that the safety provided by FMT was related to elevated bile acid metabolites in each people and mice.

The authors famous a rise in bile acid metabolites in each people and mice.

When the researchers eliminated bile salt hydrolase, an essential enzyme in bile acid metabolism, from the Bacteroides micro organism in mice, they discovered that the elevated peanut tolerance was eliminated.

These findings in mice recommend that bile salt hydrolase produced by Bacteroides micro organism might assist scale back peanut allergy. Nonetheless, this a part of the examine was not performed in people.

Whereas the examine’s findings present promise, FMT can not but be really helpful as a remedy for allergy symptoms.

Rachid mentioned the potential subsequent steps for the analysis. “We wish to administer a extra purified type of FMT, referred to as MTT (microbiota transplantation remedy), that has lower than 1% nonmicrobial fecal materials,” she stated.

“MTT might be saved in a house fridge. We wish to consider its impact after extended administration, to see if sufferers can tolerate increased doses, and consider if efficacy is extra extended. It’s vital to obtain funding to assist future trials to advance the microbiome therapeutics in meals allergy. With ample funding assist, and if the impact is confirmed in future trials, it’s attainable we would see medical purposes in 10 to fifteen years,” Rachid continued.

Bakhtiar agreed that microbiome remedy for peanut allergy symptoms could possibly be attainable in 10 years, “if the bigger trials maintain up.”

“You continue to want larger research, a clearer concept of who responds, a safer and extra standardized product than whole-stool capsules, and proof that the safety lasts. What folks ought to do now stays unchanged: strict avoidance, an emergency plan, and specialist allergy care. If an outlined bacterial or metabolite remedy comes out of this, that’s when the dialog adjustments,” Bakhtiar stated.